15th Apr 2024 7:00 am |
RNS |
Annual Report & Notice of AGM |
9th Apr 2024 7:09 am |
RNS |
Final results |
27th Mar 2024 7:00 am |
RNS |
Notice of Results |
22nd Mar 2024 3:03 pm |
RNS |
Holding(s) in Company |
14th Mar 2024 7:00 am |
RNS |
Holding(s) in Company |
15th Feb 2024 7:00 am |
RNS |
Long Term Incentive Plan / PDMR Notification |
14th Feb 2024 1:14 pm |
RNS |
Result of Secondary Placing |
14th Feb 2024 7:00 am |
RNS |
Proposed Secondary Placing of Ordinary Shares |
2nd Feb 2024 12:44 pm |
RNS |
Holding(s) in Company |
30th Jan 2024 7:00 am |
RNS |
Trading update |
8th Jan 2024 7:00 am |
RNS |
Broker change |
2nd Jan 2024 7:00 am |
RNS |
£6.3m HRV contract signed with biotech client |
13th Dec 2023 7:00 am |
RNS |
£16.8m RSV contract & Trading ahead of guidance |
5th Oct 2023 7:00 am |
RNS |
Positive results from flu human challenge study |
12th Sep 2023 7:00 am |
RNS |
Interim results |
1st Sep 2023 7:00 am |
RNS |
Exercise of Warrants |
29th Aug 2023 7:00 am |
RNS |
Plans for a new larger state-of-the-art facility |
24th Aug 2023 7:00 am |
RNS |
Notice of Results |
26th Jul 2023 7:00 am |
RNS |
Trading update |
25th Jul 2023 7:00 am |
RNS |
Flu B challenge model |
28th Jun 2023 7:00 am |
RNS |
hMPV human challenge model |
14th Jun 2023 8:00 am |
RNS |
Director dealings |
23rd May 2023 12:36 pm |
RNS |
Result of AGM |
28th Apr 2023 7:00 am |
RNS |
Annual Report and Notice of AGM |
26th Apr 2023 7:00 am |
RNS |
FDA Breakthrough and Fast Track for US biotech |
25th Apr 2023 7:00 am |
RNS |
Final results |
19th Apr 2023 7:10 am |
RNS |
Notice of Results |
6th Apr 2023 3:54 pm |
RNS |
Holding(s) in Company |
3rd Apr 2023 7:00 am |
RNS |
Positive results from flu human challenge study |
29th Mar 2023 7:00 am |
RNS |
Presentation at World Vaccine Congress |
23rd Mar 2023 7:00 am |
RNS |
Exercise of Options |
16th Mar 2023 7:00 am |
RNS |
Omicron human challenge model update |
6th Feb 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
6th Feb 2023 9:00 am |
RNS |
Price Monitoring Extension |
6th Feb 2023 7:05 am |
RNS |
Long Term Incentive Plan / PDMR Notification |
6th Feb 2023 7:00 am |
RNS |
£6.8m RSV human challenge contract signed |
25th Jan 2023 9:06 am |
RNS |
Second Price Monitoring Extn |
25th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
25th Jan 2023 7:00 am |
RNS |
Trading update |
17th Jan 2023 7:00 am |
RNS |
EUR3.2m Venn contract with global pharma client |